83 results
Page 3 of 5
8-K
EX-10.1
o7iwcct365n3
9 Feb 21
Orchard Therapeutics Announces $150 Million Strategic Financing
7:10am
8-K
EX-99.2
5jz0lw fggb
9 Feb 21
Orchard Therapeutics Announces $150 Million Strategic Financing
7:10am
8-K
EX-99.1
7ns0l
29 Jan 21
Orchard Therapeutics Appoints Braden Parker as Chief Commercial Officer
7:03am
8-K
EX-99.1
6ogediz1w5htva3
11 Jan 21
Results of Operations and Financial Condition
7:05am
8-K
ko1jf1p9e qrcbmkhk
11 Jan 21
Results of Operations and Financial Condition
7:05am
8-K
EX-99.1
jyfcsf9t2h
8 Dec 20
Other Events
7:03am
10-Q
sk4oqg4ub097fa fy9
7 May 20
Quarterly report
4:03pm
DEF 14A
a5sl xd389sd3721khaq
29 Apr 20
Definitive proxy
4:02pm
PRE 14A
hll9jsp
14 Apr 20
Preliminary proxy
4:46pm
8-K
EX-99.1
v1t 8r5uingvqvi
31 Mar 20
Other Events
4:08pm
10-K
kdvl7q392c ra
27 Feb 20
Annual report
4:02pm
8-K
EX-99.1
t4ux9ap6ut
27 Feb 20
Orchard Therapeutics Reports 2019 Financial Results and Reviews Key Strategic Priorities for 2020
7:04am
8-K
EX-99.1
37tz prqsn
3 Feb 20
Orchard Therapeutics Appoints Industry Veteran Steven Altschuler, M.D. to its Board of Directors
7:28am
8-K
EX-99.2
nawnl2y3wt
13 Jan 20
Orchard Therapeutics Highlights 2020 Strategic Priorities
7:20am
8-K
qa1e6qld
13 Jan 20
Orchard Therapeutics Highlights 2020 Strategic Priorities
7:20am
8-K
EX-99.1
y7e2t 5eq0iyct
13 Jan 20
Orchard Therapeutics Highlights 2020 Strategic Priorities
7:20am
6-K
EX-99.2
ow69fnmy53ckac 0yji
6 Nov 19
Orchard Therapeutics to Present New Registrational Data of Investigational Gene Therapies at the 61st American Society of Hematology Annual Meeting
4:07pm